Submitted by endpointsnews6292 in business
Madrigal Pharmaceuticals has appointed ex-Sanofi executive Bill Sibold as its new CEO, succeeding Paul Friedman, who will continue to serve on the biotech's board of directors. Sibold was previously executive vice president of specialty care at Sanofi, where …